A brief overview of tyrosine hydroxylase and α-synuclein in the Parkinsonian brain
- PMID: 22583430
- DOI: 10.2174/187152712800792929
A brief overview of tyrosine hydroxylase and α-synuclein in the Parkinsonian brain
Abstract
Parkinson's disease (PD) is associated with neurodegeneration of the nigrostriatal tract and is accompanied with loss of tyrosine hydroxylase (TH) and dopamine (DA). Development of neuroprotective strategies targeting PD is often undermined by lack of proper understanding of processes contributing to the pathology. In this mini review we have tried to briefly outline the involvement of TH and α-synuclein in PD. Aberrant expression of α-synuclein is toxic to dopaminergic neurons. It interacts with ubiquitin-proteasomal processing system, implicated in oxidative injury and mitochondrial dysfunction which ultimately induce neurodegenration and cell death. The contributions of DJ-1 in TH regulation have also been discussed. Brain specific TH expression with the combined use of the pegylated immunoliposome (PILs) gene transfer technology and brain specific promoters as a new approach to treat PD has also been included.
Similar articles
-
Current status of tyrosine hydroxylase in management of Parkinson's disease.CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):450-5. doi: 10.2174/187152712800792910. CNS Neurol Disord Drug Targets. 2012. PMID: 22583428 Review.
-
A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):395-409. doi: 10.2174/187152712800792785. CNS Neurol Disord Drug Targets. 2012. PMID: 22483313 Free PMC article. Review.
-
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x. Acta Neuropathol Commun. 2017. PMID: 28143577 Free PMC article.
-
A role for alpha-synuclein in the regulation of dopamine biosynthesis.J Neurosci. 2002 Apr 15;22(8):3090-9. doi: 10.1523/JNEUROSCI.22-08-03090.2002. J Neurosci. 2002. PMID: 11943812 Free PMC article.
-
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Free Radic Biol Med. 2013. PMID: 23743292 Review.
Cited by
-
Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.Mol Cell Neurosci. 2019 Jul;98:140-154. doi: 10.1016/j.mcn.2019.06.004. Epub 2019 Jun 12. Mol Cell Neurosci. 2019. PMID: 31201929 Free PMC article.
-
The Association Between Parkinson's Disease and Attention-Deficit Hyperactivity Disorder.Cell Transplant. 2020 Jan-Dec;29:963689720947416. doi: 10.1177/0963689720947416. Cell Transplant. 2020. PMID: 33028106 Free PMC article.
-
Behavior, PET and histology in novel regimen of MPTP marmoset model of Parkinson's disease for long-term stem cell therapy.Tissue Eng Regen Med. 2015 Dec 28;13(1):100-109. doi: 10.1007/s13770-015-0106-3. eCollection 2016 Feb. Tissue Eng Regen Med. 2015. PMID: 30603390 Free PMC article.
-
Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.PLoS One. 2013 Oct 18;8(10):e78220. doi: 10.1371/journal.pone.0078220. eCollection 2013. PLoS One. 2013. PMID: 24205164 Free PMC article.
-
Active lifestyle enhances protein expression profile in subjects with Lewy body pathology.Dement Neuropsychol. 2021 Jan-Mar;15(1):41-50. doi: 10.1590/1980-57642021dn15-010004. Dement Neuropsychol. 2021. PMID: 33907596 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical